Test ID CEASF Carcinoembryonic Antigen (CEA), Spinal Fluid
Useful For
Detecting meningeal carcinomatosis and intradural or extradural infiltration
Differentiating brain parenchymal metastasis from adenocarcinoma or squamous-cell carcinoma
Method Name
Immunoenzymatic Assay
Reporting Name
Carcinoembryonic Ag (CEA), CSFSpecimen Type
CSFSpecimen Required
Collection Container/Tube: Sterile vial
Submission Container/Tube: 13 x 75-mm tube
Specimen Volume: 0.5 mL
Specimen Minimum Volume
0.4 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
CSF | Refrigerated (preferred) | 14 days |
Frozen | 90 days | |
Ambient | 7 days |
Reference Values
<0.6 ng/mL
Tumor markers are not specific for malignancy, and values may vary by method.
Day(s) Performed
Monday through Saturday
Performing Laboratory

CPT Code Information
82378
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CEASF | Carcinoembryonic Ag (CEA), CSF | 2037-0 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
CEASF | Carcinoembryonic Ag (CEA), CSF | 2037-0 |
Test Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.Report Available
1 to 3 daysNY State Approved
YesForms
If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.